The Latest Breaking News from Disease

Huntington’s disease is a fatal neurological condition.

In a landmark clinical trial, uniQure's gene therapy AMT-130 slowed Huntington's disease progression by 75% over 3 years. The one-time treatment may mark the first disease-modifying therapy for this incurable neurodegenerative condition.

Surgical procedure to treat devastating illness slowed progress of disease by 75% in patients after three years

The condition, which currently has no cure, has been slowed in a groundbreaking trial

University College London experts say the finding could ‘change everything’ for patients with the condition

A new study has pinpointed the earliest features of MS

AS TOLD TO : Frédéric Roscop, 49, contracted Lyme disease aged five years old but wasn’t diagnosed with it until his mid-thirties. He tells Charlotte Cripps about his lifelong battle with the disease, along with co-infections and associated mental health challenges, and how he found his way to a normal…

James Hird has thrown his support behind the latest initiative from 13-year-old Harrison Pennicott, who has autoimmune disease Scleroderma, and Dyson Heppell.

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.